Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Indoco Remedies has informed that Competent Health Authority of Malta had inspected Company’s manufacturing facility for solid oral dosage form (Unit I) located at Baddi (‘Facility’), from April 20, 2023 to April 24, 2023. The Facility has received EU GMP certification from Competent Health Authority of Malta confirming that the Facility complies with the Good Manufacturing Practice requirements as referred in the EC Directive. The company has enclosed press release in this regard.
The above information is a part of company’s filings submitted to BSE.
